Louis Moore Bacon's AGIO Position Overview
Louis Moore Bacon (via Moore Capital Management, Lp) currently holds 150,000 shares of Agios Pharmaceuticals, Inc. (AGIO) worth $4.08 M, representing 0.06% of the portfolio. First purchased in 2024-Q2, this short-term holding has been held for 7 quarters.
Based on 13F filings, Louis Moore Bacon has maintained this position in AGIO for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 95,000 shares. Largest reduction occurred in Q4 2024, reducing 40,000 shares.
Analysis based on 13F filings available since 2013 Q2
Louis Moore Bacon's Agios Pharmaceuticals (AGIO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Agios Pharmaceuticals (AGIO) Trades by Louis Moore Bacon
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +95,000 | Add 172.73% | 150,000 | $27.22 |
| Q3 2025 | -25,000 | Reduce 31.25% | 55,000 | $40.14 |
| Q2 2025 | +20,000 | Add 33.33% | 80,000 | $33.26 |
| Q4 2024 | -40,000 | Reduce 40.00% | 60,000 | $32.86 |
| Q3 2024 | +40,000 | Add 66.67% | 100,000 | $44.43 |
| Q2 2024 | +60,000 | New Buy | 60,000 | $43.12 |
Louis Moore Bacon's Agios Pharmaceuticals Investment FAQs
Louis Moore Bacon first purchased Agios Pharmaceuticals, Inc. (AGIO) in Q2 2024, acquiring 60,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon has held Agios Pharmaceuticals, Inc. (AGIO) for 7 quarters since Q2 2024.
Louis Moore Bacon's largest addition to Agios Pharmaceuticals, Inc. (AGIO) was in Q4 2025, adding 150,000 shares worth $4.08 M.
According to the latest 13F filing for Q4 2025, Louis Moore Bacon's firm, Moore Capital Management, Lp, owns 150,000 shares of Agios Pharmaceuticals, Inc. (AGIO), valued at approximately $4.08 M.
As of the Q4 2025 filing, Agios Pharmaceuticals, Inc. (AGIO) represents approximately 0.06% of Louis Moore Bacon's publicly disclosed stock portfolio, making it one of their key holdings.
Louis Moore Bacon's peak holding in Agios Pharmaceuticals, Inc. (AGIO) was 150,000 shares, as reported at the end of Q4 2025.